Cirrhosis other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
===Nuclear Imaging===
===Nuclear Imaging===
====Tc-99m====
====Tc-99m====
Tc-99m labeled sulfur used for functional imaging techniques provides some indication of hepatic function.  The labeled colloidal compound is taken up by [[reticuloepithelial]] cells, and it is the colloidal shift to the other organs (bone marrow, spleen) containing reticuloepithelial cells that provides evidence of portal hypertension. <ref>{{cite journal |author=Kim YS, Cho SW, Lee KJ, ''et al.'' |title=Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma |journal=Clin Nucl Med |volume=24 |issue=11 |pages=874–9 |year=1999 |month=November |pmid=10551471 |doi= |url=}}</ref>


==References==
==References==

Revision as of 15:47, 6 September 2012

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis other imaging findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis other imaging findings

CDC on Cirrhosis other imaging findings

Cirrhosis other imaging findings in the news

Blogs on Cirrhosis other imaging findings

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Other Imaging Findings

Nuclear Imaging

Tc-99m

Tc-99m labeled sulfur used for functional imaging techniques provides some indication of hepatic function. The labeled colloidal compound is taken up by reticuloepithelial cells, and it is the colloidal shift to the other organs (bone marrow, spleen) containing reticuloepithelial cells that provides evidence of portal hypertension. [1]

References

  1. Kim YS, Cho SW, Lee KJ; et al. (1999). "Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma". Clin Nucl Med. 24 (11): 874–9. PMID 10551471. Unknown parameter |month= ignored (help)


Template:WH Template:WS